期刊文献+

探讨慢性乙型肝炎的抗病毒西药剂治疗临床效果

下载PDF
导出
摘要 目的探讨抗病毒西药剂治疗慢性乙型肝炎的临床效果。方法以住院部所收治的确诊为慢性乙型肝炎疾病的患者共计100例作为研究对象,根据数字随机表方法进行分组,50例患者纳入对照组,50例患者纳入观察组。对照组用药方案为替比夫定。观察组用药方案为恩替卡韦。结果观察组患者ALT复常率为76.00%(38/50)、HBV-DNA转阴率为70.00%(35/50)、HBe Ag转阴率为34.00%(17/50)、Hbe Ag转换率为10.00%(5/50),以上数据与对照组患者对比无明显差异,P>0.05,没有统计学意义。结论替比夫定以及恩替卡韦作为典型的抗病毒西药剂,在治疗慢性乙型肝炎疾病方面的临床疗效相当,可根据实际情况在临床用药中合理应用。
作者 韩笑
出处 《全科口腔医学电子杂志》 2018年第23期64-65,共2页 Electronic Journal of General Stomatology
  • 相关文献

参考文献3

二级参考文献63

  • 1Qian-Guo Mao, Ru-Mian Zhang, Jin-Shui Pan,Kuang-Nan Fang, Jian-Ping Zhu,Qing-Yang Hong.Precise prediction model and simplified scoring system for sustained combined response to interferon-α[J].World Journal of Gastroenterology,2010,16(27):3465-3471. 被引量:6
  • 2Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures [ J ]. J Viral Hepat, 2004, 11 (2) : 97-107.
  • 3Liu Y, Lou G, Wu W, et al. Interferon-alpha sensitizes HBx- expressing hepatocarcinoma cells to chemotherapeutic drugs through inhibition of HBx-mediated NF-kappaB activation [J]. Virol J, 2013,10( 1 ) : 168.
  • 4Karabay O, Tuna N, Esen S. Comparative efficacy of pegylated interferons a-2a and 2b in the treatment of HBeAg-negative chronic hepatitis B infection [J]. Eur J Gastroenterol Hepatol, 2012,24(11) : 1296-1301.
  • 5Yu HB, Liu EQ, Lu SM, et al. Treatment with peginterferon versus interferon in Chinese patients with hepatitis B [J]. Biomed Pharmaeother, 2010,64(8):559-564.
  • 6Cai G, Jiang M, Zhang B, et al. Preparation and biological evaluation of a glyeosylated fusion interferon directed to hepatic receptors [ J ]. Biol Pharm Bull, 2009,32 ( 3 ) : 440-443.
  • 7Cai G, Jiang M, Zhou Y, et al. Generation of a liver targeting fusion interferon and its bioactivity analysis in vitro I[J]. Phannazie, 2011,66 (10) : 761-765.
  • 8Fasano M, Lampertieo P, Marzano A, et al. HBV DNA suppression and HBsAg elearanee in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years [J]. J Hepatol, 2012,56(6) : 1254-1258.
  • 9Liaw YF, Sung JJ. Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease [J]. N Engl J Med, 2004, 351 (15) : 1521-1531.
  • 10Mareellin P, Chang Tr, Lim SG, et al. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronie hepatitis B [J]. Hepatology, 2008,48 (3) :750-758.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部